AXGN Q2 2017 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$15M+46.1% YoY

Gross Profit

$13M85.0% margin

Operating Income

-$1M-9.5% margin

Net Income

-$2M-13.6% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+23.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$724,377

Balance Sheet

Total Assets

$43M

Total Liabilities

$31M

Stockholders' Equity

$11M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$10M	+46.1%
Gross Profit	$13M	$9M	+45.7%
Operating Income	-$1M	-$2M	+10.0%
Net Income	-$2M	-$3M	+26.5%